GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Endoscopy/ESD – does techniques matter?(Endoscopy, Jan-2026)

ESD – does techniques matter?(Endoscopy, Jan-2026)

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated January 1, 2026

Quick Answer

Yes, techniques for Endoscopic Submucosal Dissection (ESD) matter significantly, as different techniques demonstrate varying advantages and outcomes depending on the clinical scenario. Based on the synthesized evidence from 18 randomized controlled trials (RCTs) involving 2,677 patients, three major techniques for ESD were compared: 1.


Yes, techniques for Endoscopic Submucosal Dissection (ESD) matter significantly, as different techniques demonstrate varying advantages and outcomes depending on the clinical scenario. Based on the synthesized evidence from 18 randomized controlled trials (RCTs) involving 2,677 patients, three major techniques for ESD were compared:

1. **Tunnel/Pocket Method (Tu-ESD)**

2. **Traction Method (Tr-ESD)**

3. **Conventional Method (C-ESD)**

### Key Findings:

  • **Tu-ESD** achieved the highest ranking for **curative resection** (score 92.1) and was best for minimizing adverse events.
  • **Tr-ESD** ranked highest for **reducing procedure time** (score 100) and demonstrated significant reductions in procedure time compared with C-ESD (mean difference: –18.74 minutes).
  • Subgroup analyses by colorectal, gastric, and esophageal locations showed that:
  • **Tr-ESD** was superior for en bloc resection and procedure time.
  • **Tu-ESD** was best for curative resection and minimizing adverse events.

### Conclusion:

Both Tu-ESD and Tr-ESD were found to be effective and safe compared to the conventional method (C-ESD). Given that different techniques offer distinct advantages, the choice of ESD technique should be tailored to the specific clinical scenario, lesion location, and procedural goals. This highlights the importance of selecting the appropriate method to optimize outcomes in ESD procedures.

Related Q&A

EndoBarrier Improves Diabetes and Weight Loss: Ann Surg | July 2026

Introduction: Endoscopic metabolic therapies have emerged as less invasive alternatives to bariatric surgery for patients with obesity and poorly controlled type 2 diabetes mellitus (T2DM). The EndoBarrier duodenal-jejunal bypass liner (DJBL) is an endoscopically placed...

Immediate Endoscopic Necrosectomy in Necrotizing Pancreatitis: Gastroenterology | July 2026

Introduction: Endoscopic ultrasound (EUS)-guided transmural drainage is the standard minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...

Endoscopy After Bevacizumab Appears Safe: GIE | July 2026

Introduction: Bevacizumab is widely used in metastatic colorectal cancer (mCRC) because of its survival benefits but is associated with impaired wound healing, gastrointestinal perforation, and bleeding. These concerns often lead clinicians to delay endoscopic procedures...

Colorectal ESD Perforation: Endoscopy | July 2026

Introduction: Endoscopic submucosal dissection (ESD) enables en bloc resection of large colorectal neoplasms with excellent oncological outcomes. However, concerns about perforation have limited its widespread adoption. This large prospective multicenter study evaluated the incidence, risk...

Duodenal Mucosal Resurfacing REMAIN-1 Study: DDW | 2026

Introduction: Obesity has become one of the greatest global health challenges. New incretin-based therapies—including semaglutide, tirzepatide, resmetirom, and SGLT2 inhibitors such as empagliflozin—have transformed the treatment of obesity, diabetes, and MASLD. However, many patients discontinue...

EUS-FNAB for Solid Pancreatic Lesions: GIE | July 2026

Introduction: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support. This multicenter prospective study evaluated whether directly placing...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer